Thrombopoietin participates in platelet activation in COVID-19 patients

BACKGROUND: The pathogenesis of coronavirus disease 2019 (COVID-19) is characterized by enhanced platelet activation and diffuse hemostatic alterations, which may contribute to immunothrombosis/thromboinflammation and subsequent development of target-organ damage. Thrombopoietin (THPO), a growth fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Lupia, Enrico, Capuano, Marialessia, Vizio, Barbara, Schiavello, Martina, Bosco, Ornella, Gelardi, Maria, Favale, Edoardo, Pivetta, Emanuele, Morello, Fulvio, Husain, Shahid, Keshavjee, Shaf, Del Sorbo, Lorenzo, Montrucchio, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556163/
https://www.ncbi.nlm.nih.gov/pubmed/36242922
http://dx.doi.org/10.1016/j.ebiom.2022.104305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556163/
https://www.ncbi.nlm.nih.gov/pubmed/36242922
http://dx.doi.org/10.1016/j.ebiom.2022.104305

Ejemplares similares